Universal-Beteiligungs- und Servicegesellschaft’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Sell
282,040
-2,838
-1% -$1.05M 0.17% 105
2026
Q1
$90.2M Buy
284,878
+25,841
+10% +$8.49M 0.16% 122
2025
Q4
$95.6M Sell
259,037
-21,341
-8% -$7.21M 0.16% 114
2025
Q3
$90.6M Sell
280,378
-35,973
-11% -$11.2M 0.15% 119
2025
Q2
$123M Buy
316,351
+6,004
+2% +$2.41M 0.22% 92
2025
Q1
$135M Sell
310,347
-1,816
-0.6% -$729K 0.27% 76
2024
Q4
$115M Buy
+312,163
New +$131M 0.23% 86

Other funds holding ELV

Universal-Beteiligungs- und Servicegesellschaft's ELV Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Elevance Health (ELV) stake by 1% in Q2 2026, selling an estimated $1.05M and leaving 282,040 shares worth $113M. The position accounts for 0.17% of the portfolio, ranked #105.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $135M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 282,040 shares of Elevance Health worth $113M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,838 Elevance Health shares in Q2 2026, an estimated $1.05M.
  • Elevance Health made up 0.17% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #105 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Elevance Health position peaked at $135M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.